Two Sigma Securities, LLC Bio Cardia, Inc. Put Options Transaction History
Two Sigma Securities, LLC
- $10.3 Billion
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding BCDA
# of Institutions
24Shares Held
1.95MCall Options Held
17.2KPut Options Held
0-
Cm Management, LLC700KShares$2.09 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA651KShares$1.95 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA156KShares$466,0180.0% of portfolio
-
Family Management Corp New York, NY77.5KShares$231,7250.01% of portfolio
-
Black Rock Inc. New York, NY45.9KShares$137,2140.0% of portfolio
About BioCardia, Inc.
- Ticker BCDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,758,200
- Market Cap $53.1M
- Description
- BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...